Ayahuasca is a psychoactive brew or tea most commonly derived from Banisteriopsis caapi, a vine containing monoamine oxidase inhibitors (MAOIs), and the leaves of Psychotria viridis or other plant containing N,N-dimethyltryptamine (DMT), and often several other admixture plants.
Did you know?
Ayahuasca is legal in many countries in South America.
MAPS completed the first North American observational study of the safety and long-term effectiveness of ayahuasca treatment for addiction and dependence.
In the United States, the União do Vegetal and the Santo Daime Church have been granted legal freedom to use ayahuasca for religious purposes, though DMT, the principally active ingredient, remains a Schedule I controlled substance.
Summary: On a new episode of Red Table Talk, Jaden Smith, Jada Pinkett Smith, and Gammy Norris speak with author Michael Pollan, journalist Lisa Ling, oncologist Paul Song, and entrepreneur Bob Parsons …
Summary: WIRED investigates the growth of support for psychedelic medicine, highlighting how entrepreneurs from the technology industry are contributing to the field through philanthropic contributions …
Summary: Cory Stieg of CNBC Make It illustrates the details of psychedelic-assisted therapy sessions, pulling from the expertise of MAPS-sponsored researcher Jennifer Mitchell, Ph.D., and Corine de Boer, …
Summary: In an opinion piece for Baltimore Sun, Monnica Williams, Ph.D., and Morgan Campbell, M.D., provide a compelling argument for expediting access to psychedelic-assisted therapy, including MDMA-assisted …
Originally appearing here. This all new episode of the MAPS Podcast features an interview between Rachel Harris and host Zach Leary. Rachel’s kindness, wisdom and dedication to the expansion of knowledge …
Summary: In an exclusive interview with Rolling Stone, Ethan Nadelmann, Drug Policy Alliance Founder and former Executive Director, discusses his new podcast, Psychoactive! Rolling Stone explains that …
Summary: In The New York Times, bestselling author Michael Pollan considers the multiple possible paths of integrating psychedelics, as well as other currently illegal substances, into society after decades …
Summary: “Just because a drug can be enjoyed or misused, or has been associated with a counterculture or a particular set of political values, that shouldn’t mean that it ought to be locked away …
Summary: Psychedelic research “studies that have been completed, while preliminary, have been nothing short of amazing,” declares Good Housekeeping, as advancements in psychedelic science continue …
Summary: Healthline provides a well-rounded overview about the basics of psychedelic-assisted therapy, including the current research applications and statuses of various psychedelics, stages of the therapeutic …
Summary: In an interview with Imperial College London, psychedelic researcher Leor Roseman, Ph.D., describes the findings and potential implications of an observational study investigating relational processes …
Summary: Author Bill Alpert of Barron’s contrasts MAPS’ leading non-profit and public benefit models with the profit-oriented approach of new psychedelic companies. “None of the for-profits …